HC Wainwright Reiterates “Buy” Rating for Balchem (NASDAQ:BCPC)

HC Wainwright reaffirmed their buy rating on shares of Balchem (NASDAQ:BCPC) in a research note issued to investors on Monday,Benzinga reports. They currently have a $190.00 price objective on the basic materials company’s stock. HC Wainwright also issued estimates for Balchem’s Q1 2025 earnings at $0.99 EPS, Q2 2025 earnings at $1.03 EPS, Q3 2025 earnings at $1.08 EPS, Q4 2025 earnings at $1.12 EPS, FY2025 earnings at $4.22 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.17 EPS, Q3 2026 earnings at $1.20 EPS, Q4 2026 earnings at $1.22 EPS and FY2026 earnings at $4.71 EPS.

Separately, StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

Balchem Stock Down 0.5 %

BCPC opened at $172.69 on Monday. Balchem has a twelve month low of $137.69 and a twelve month high of $186.03. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The firm has a 50 day moving average price of $162.13 and a 200-day moving average price of $169.46. The stock has a market capitalization of $5.61 billion, a price-to-earnings ratio of 43.94, a PEG ratio of 4.41 and a beta of 0.69.

Balchem (NASDAQ:BCPC) last announced its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). The company had revenue of $240.00 million for the quarter, compared to analysts’ expectations of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. Equities research analysts forecast that Balchem will post 4.64 earnings per share for the current year.

Balchem Increases Dividend

The firm also recently announced an annual dividend, which was paid on Friday, January 17th. Shareholders of record on Thursday, December 26th were issued a dividend of $0.87 per share. This is a boost from Balchem’s previous annual dividend of $0.79. This represents a yield of 0.4%. The ex-dividend date of this dividend was Thursday, December 26th. Balchem’s dividend payout ratio is currently 22.14%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Quadrant Capital Group LLC lifted its position in Balchem by 8.2% during the fourth quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company’s stock valued at $161,000 after purchasing an additional 75 shares in the last quarter. Covestor Ltd increased its position in Balchem by 93.8% in the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company’s stock worth $26,000 after buying an additional 76 shares in the last quarter. Arizona State Retirement System raised its stake in shares of Balchem by 0.8% in the fourth quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company’s stock worth $1,534,000 after buying an additional 77 shares during the period. Vident Advisory LLC lifted its position in shares of Balchem by 6.0% during the 4th quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company’s stock valued at $232,000 after buying an additional 80 shares in the last quarter. Finally, Mackenzie Financial Corp grew its stake in shares of Balchem by 2.2% during the 4th quarter. Mackenzie Financial Corp now owns 3,840 shares of the basic materials company’s stock valued at $626,000 after acquiring an additional 84 shares during the period. Hedge funds and other institutional investors own 87.91% of the company’s stock.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.